Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
HUMULIN R ELI LILLY CANADA INC Resolved 100UNIT Updated Report 2024-09-18 236640
LANCORA SERVIER CANADA INC Resolved 5MG Updated Report 2024-09-18 237006
MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC Actual shortage 20MG 500MG Updated Report 2024-09-18 237812
EMEND IV MERCK CANADA INC Actual shortage 150MG Updated Report 2024-09-18 237846
ACCUTANE ROCHE HOFFMANN-LA ROCHE LIMITED Resolved 10MG Updated Report 2024-09-18 229980
TEGRETOL CR NOVARTIS PHARMACEUTICALS CANADA INC Anticipated shortage 200MG Updated Report 2024-09-17 235978
VOLTAREN RAPIDE NOVARTIS PHARMACEUTICALS CANADA INC Anticipated shortage 50MG Updated Report 2024-09-17 233544
TEGRETOL NOVARTIS PHARMACEUTICALS CANADA INC Anticipated shortage 200MG Updated Report 2024-09-17 235974
ACCUTANE ROCHE HOFFMANN-LA ROCHE LIMITED Anticipated shortage 40MG Updated Report 2024-09-17 229983
CELLCEPT HOFFMANN-LA ROCHE LIMITED Anticipated shortage 250MG New Report 2024-09-17 237837

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-09-16 224344
TARO-DIPYRIDAMOLE/ ASA TARO PHARMACEUTICALS INC Discontinued 25MG 200MG New Report 2024-09-09 237043
HUMALOG ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-09-05 224347
GLUCONORM 2.0MG NOVO NORDISK CANADA INC Discontinued 2.0MG Updated Report 2024-09-05 201489
LEVOPHED PFIZER CANADA ULC Discontinued 1MG Updated Report 2024-08-29 236113